Advertisements
Advertisements
Question
Explain how recombinant human insulin was prepared in 1983 by Eli Lily an American company.
Advertisements
Solution
1983, Eli Lilly an American company prepared two DNA sequences corresponding to A and B, chains of human insulin and introduced them in plasmids of E. coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulfide bonds to form human insulin.
APPEARS IN
RELATED QUESTIONS
How did an American Company, Eli Lilly use the knowledge of r-DNA technology to produce human insulin?
Compare and contrast the advantages and disadvantages of the production of genetically modified crops.
State the best-known contribution of P.K. Sethi
What is gene therapy? Name the first clinical case in which it was used.
PCR proceeds in three distinct steps governed by temperature, they are in order of ____________.
Which of the following is a neuropeptide hormone?
Human insulin is being commercially produced forma transgenic species of ______.
With regard to insulin choose the correct options.
- C-peptide is not present in mature insulin.
- The insulin produced by rDNA technology has C-peptide.
- The pro-insulin has C-peptide.
- A-peptide and B-peptide of insulin are interconnected by disulphide bridges.
Choose the correct answer from the options given below.
Taking examples under each category, discuss upstream and downstream processing.
How is a mature, functional insulin hormone different from its prohormone form?
